The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: Revisiting the enigma

Current Psychiatry Reports

Volumn 15, Issue 4, 2013, Pages

  Christley, Yvonne ^a   Duffy, Tim ^a   Everall, Ian Paul ^b   Martin, Colin R ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Attention; CFS; Chronic fatigue syndrome; Depression; Generalised anxiety disorder; Major depressive disorder; MDD; Memory Reaction time; Neuropsychiatric; Neuropsychological; Personality disorder; Somatoform disorder

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; CHRONIC FATIGUE SYNDROME; DISEASE ASSOCIATION; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MEMORY DISORDER; NITROSATIVE STRESS; OXIDATIVE STRESS; PERSONALITY DISORDER; REACTION TIME; SOMATOFORM DISORDER;

EID: 84874054575     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-013-0353-8     Document Type: Article

References (85)

1. Christley Y, Duffy T, Martin CR. A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract. 2012;18:25-31.
2. Jason LA, Taylor R, Wagner L, Holden J, Ferrari JR, Plioplys AV, et al. Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study. Am J Community Psychol. 1995;23:557-68.
3. Jason LA, Porter N, Hunnell J, Brown A, Rademaker A, Richman JA. A natural history study of chronic fatigue syndrome. Rehabil Psychol. 2011;56:32-42.
4. Buchwald D, Pearlman T,Umali J, Schmaling K, Katon W. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med. 1996;101:364-70. (Pubitemid 26392853)
5. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996;34:924-30. (Pubitemid 126465550)
6. McCrone P, Darbishire L, Ridsdale L, Seed P. The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med. 2003;33:253-61. (Pubitemid 36221457)
7. Ross SD, Estok RP, Frame D, Stone LR, Ludensky V, Levine CB. Disability and chronic fatigue syndrome: a focus on function. Arch Intern Med. 2004;164:1098-107. (Pubitemid 38668989)
8. Manu P, Affleck G, Tennen H, Morse PA, Escobar JI. Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. Psychother Psychosom. 1996;65:76-81. (Pubitemid 26095799)
9. Fuller-Thomson E, Nimigon J. Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey. Fam Pract. 2008;25:414-22.
10. Iwase M, Okajima R, Takahashi T, Mogami N, Kusaka H, Takeda M, et al. Psychiatric treatment and assessment of chronic fatigue syndrome in Japan. In: Watanabe Y, Evengard B, Natelson BH, Jason LA, Kuratsune H, editors. Fatigue science for human health. Springer: London; 2008. p. 103-19.
11. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatr. 1996;153:1050-9. (Pubitemid 26264706)
12. Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. CIBA Found Symp. 1993;173:23-31.
13. Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol. 1998;57 Suppl 2:94-6. (Pubitemid 29011491)
14. Buchwald D, Pearlman T, Kith P, Katon W, Schmaling K. Screening for psychiatric disorders in chronic fatigue and chronic fatigue syndrome. J Psychosom Res. 1997;42:87-94. (Pubitemid 27095717)
15. Van Houdenhove B, Kempke S, Luyten P. Psychiatric aspects of chronic fatigue syndrome and fibromyalgia. Curr Psychiatr Rep. 2010;12:208-14.
16. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012;36:764-85.
17. Axe EK, Satz P, Rasgon NL, Fawzy FI. Major depressive disorder in chronic fatigue syndrome: a CDC Surveillance Study. J Chron Fatigue Syndr. 2004;12:7-23. (Pubitemid 41779178)
18. Roy-Byrne P, Afari N, Ashton S, Fischer M, Goldberg J, Buchwald D. Chronic fatigue and anxiety/depression: a twin study. Br J Psychiatry. 2002;180:29-34. (Pubitemid 34093622)
19. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study. Am J Public Health. 1997;87:1449-55. (Pubitemid 27415000)
20. Nater UM, Jones JF, Lin JM, Maloney E, Reeves WC, Heim C. Personality features and personality disorders in chronic fatigue syndrome: a population-based study. Psychother Psychosom. 2010;79:312-8.
21. Taylor RR, Jason LA, Jahn SC. Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample. Psychosom Med. 2003;65:896-901. (Pubitemid 37163401)
22. Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, et al. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. NMR In Biomed. 2010;23:643-50.
23. Zimmermann TT, Sattel HH. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528.
24. Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients-a case control study. Bmc Neurol. 2011; 11.
25. Johnson SK, DeLuca J, Natelson BH. Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. J Affect Disord. 1996;39:21-30. (Pubitemid 26235321)
26. Powell R, Dolan R, Wessely S. Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res. 1990;34:665-73.
27. Hawk C, Jason LA, Torres-Harding S. Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int J Behav Med. 2006;13:244-51. (Pubitemid 44860231)
28. Jason LA, Richman JA, Friedberg F, Wagner L, Taylor R, Jordan KM. Politics, science, and the emergence of a new disease. The case of chronic fatigue syndrome. Am Psychol. 1997;52:973-83. (Pubitemid 127681371)
29. Silver A, Haeney M, Vijayadurai P, Wilks D, Pattrick M, Main CJ. The role of fear of physical movement and activity in chronic fatigue syndrome. J Psychosom Res. 2002;52:485-93. (Pubitemid 34752343)
30. Maes M, Twisk FNM. Treatment of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), a multisystem disease, should target the pathophysiological aberrations (inflammatory and oxidative and nitrosative stress pathways), not the psychosocial "barriers" for a new equilibrium. Patient Educ Couns. 2010;80:148-9.
31. Maes M, Mihaylova I, Leunis JC. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgMmediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007;28:861-7.
32. Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J Affect Disord. 2009;115:280-6.
33. Cleare A. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 2003;24:236-52. (Pubitemid 36515286)
34. Maes M, Twisk FNM. Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. Bmc Medicine, 2010; 8.
35. Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study. Psychoneuroendocrinology, 2011.
36. Hinkelmann K, Moritz S, Botzenhardt J, Riedesel K, Wiedemann K, Kellner M, et al. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry. 2009;66:879-85.
37. Gomez RG, Posener JA, Keller J, DeBattista C, Solvason B, Schatzberg AF. Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. Psychoneuroendocrinology. 2009;34:1012-8.
38. Jerjes W, Taylor N, Wood P, Cleare A. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology. 2007;32:192-8. (Pubitemid 46274021)
39. Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med. 2008;70:298-305. (Pubitemid 351543501)
40. Nater UM, Maloney E, Boneva RS, Gurbaxani BM, Lin JM, Jones JF, et al. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab. 2008;93:703-9. (Pubitemid 351398542)
41. Turan T, Izgi HB, Ozsoy S, Tanr?verdi F, Basturk M, Asdemir A, et al. The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome. Psychiatr Investig. 2009;6:204-10.
42. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 1985;60:947-52. (Pubitemid 15085127)
43. Scott LV, Svec F, Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatr Res. 2000;97:21-8.
44. Himmel PB, Seligman TM. A pi lot study employing Dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J Clin Rheumatol. 1999;5:56-9. (Pubitemid 29217862)
45. Liang SL, Quirk D, Zhou A. RNase L: its biological roles and regulation. IUBMB Life. 2006;58:508-14. (Pubitemid 44470236)
46. Nijs J, De Meirleir K. Impairments of the 2-5A synthetase/RNaseL pathway in chronic fatigue syndrome. In Vivo. 2005;19:1013-21.
47. Suhadolnik RJ, Peterson DL, Reichenbach NL, Roen G, Metzger M, McCahan J, et al. Clinical and biochemical characteristics differentiating chronic fatigue syndrome from major depression and healthy control populations: relation to dysfunction in the RNase L pathway. J Chron Fatigue Syndr. 2004;12:5-35. (Pubitemid 39600523)
48. De Meirleir K, Bisbal C, Campine I, De Becker P, Salehzada T, Demettre E, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med. 2000;108:99-105. (Pubitemid 30064419)
49. Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry. 1990;156:534-40. (Pubitemid 20116601)
50. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatr Clin Neurosci. 1993;5:200-5. (Pubitemid 23154532)
51. Moss-Morris R, Petrie KJ. Discriminating between chronic fatigue syndrome and depression: a cognitive analysis. Psychol Med. 2001;31:469-79. (Pubitemid 32294045)
52. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatr Rev Can Psychiatr. 2006;51:100-13.
53. Stein DJ, Ruscio AM, Lee S, Petukhova M, Alonso J, Andrade LH, et al. Subtyping social anxiety disorder in developed and developing countries. Depress Anxiety. 2010;27:390-403.
54. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24:19-39. (Pubitemid 32150788)
55. Fischler B, Dendale P, Michiels V, Cluydts R, Kaufman L, De Meirleir K. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res. 1997;42:369-78. (Pubitemid 27207840)
56. Nutt DJ. Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatr. 2001;62 Suppl 11:22-7. discussion 28.
57. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatr. 1988;145:1358-68. (Pubitemid 18267374)
58. Kirmayer LJ, Robbins JM, Paris J. Somatoform disorders: personality and the social matrix of somatic distress. J Abnorm Psychol. 1994;103:125-36. (Pubitemid 24066962)
59. Abbey SE. Somatization, illness attribution and the sociocultural psychiatry of chronic fatigue syndrome. CIBA Found Symp. 1993;173:238-52. discussion 252-61.
60. Johnson SK, DeLuca J, Natelson BH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med. 1996;58:50-7. (Pubitemid 26046187)
61. Manu P, Lane TJ, Matthews DA, Escobar JI. Screening for somatization disorder in patients with chronic fatigue. Gen Hosp Psychiatr. 1989;11:294-7. (Pubitemid 19173212)
62. Demitrack MA. Neuroendocrine research strategies in chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington: American Psychiatric Press; 1993. p. 45-66.
63. Katon WJ, Walker EA. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples. CIBA Found Symp. 1993;173:193-204. discussion 204-11.
64. Katon W, Russo J. Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med. 1992;152:1604-9.
65. Johnson SK, DeLuca J, Natelson BH. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J Psychiatr Res. 1996;30:9-20. (Pubitemid 26147917)
66. Ciccone DS, Busichio K, Vickroy M, Natelson BH. Psychiatric morbidity in the chronic fatigue syndrome: Are patients with personality disorder more physically impaired? J Psychosom Res. 2003;54:445-52. (Pubitemid 38367933)
67. Moran P, Coffey C, Mann A, Carlin JB, Patton GC. Dimensional characteristics of DSM-IV personality disorders in a large epidemiological sample. Acta Psychiatr Scand. 2006;113:233-6. (Pubitemid 43340877)
68. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Curr Rheumatol Rep. 2006;8:425-9. (Pubitemid 46112733)
69. Michiels V, Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand. 2001;103:84-93. (Pubitemid 32147128)
70. Caseras X, Mataix-Cols D, Giampietro V, Rimes KA, Brammer M, Zelaya F, et al. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med. 2006;68:947-55. (Pubitemid 44808721)
71. Claypoole KH, Noonan C, Mahurin RK, Goldberg J, Erickson T, Buchwald D. A twin study of cognitive function in chronic fatigue syndrome: The effects of sudden illness onset. Neuropsychology. 2007;21:507-13. (Pubitemid 47445221)
72. Mahurin RK, Claypoole KH, Goldberg JH, Arguelles L, Ashton S, Buchwald D. Cognitive processing in monozygotic twinsdiscordant for chronic fatigue syndrome. Neuropsychology. 2004;18:232-9. (Pubitemid 38520327)
73. Deluca J, Christodoulou C, Diamond BJ, Rosenstein ED, Kramer N, Natelson BH. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J Int Neuropsychol Soc. 2004;10:101-9. (Pubitemid 38128467)
74. Chiaravalloti ND, Christodoulou C, Demaree HA, DeLuca J. Differentiating simple versus complex processing speed: influence on new learning and memory performance. J Clin Exp Neuropsychol. 2003;25:489-501. (Pubitemid 36605765)
75. Crowe SF, Casey A. A neuropsychological study of the chronic fatigue syndrome: support for a deficit in memory function independent of depression. Aust Psychol. 1999;34:70-5.
76. Fiedler N, Kipen HM, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med. 1996;58:38-49. (Pubitemid 26046186)
77. Tiersky LA, Johnson SK, Lange G, Natelson BH, DeLuca J. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol. 1997;19:560-86. (Pubitemid 27452011)
78. Cockshell S, Mathias J. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol Med. 2010;40:1253-67.
79. Majer M, Welberg LA, Capuron L, Miller AH, Pagnoni G, Reeves WC. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study. Psychosom Med. 2008;70:829-36.
80. Tiersky LA, Matheis RJ, Deluca J, Lange G, Natelson BH. Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder. J Nerv Ment Dis. 2003;191:324-31. (Pubitemid 36627207)
81. Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients-a case control study. BMC Neurol. 2011;11
82. Wearden A, Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome (CFS). Psychol Med. 1997;27:81-90. (Pubitemid 27042720)
83. Lutgendorf SK, Antoni MH, Ironson G, Fletcher MA, Penedo F, Baum A, et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom Med. 1995;57:310-23.
84. Daly E, Komaroff AL, Bloomingdale K, Wilson S, Albert MS. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Appl Neuropsychol. 2001;8:12-22. (Pubitemid 32458556)
85. Capuron L.,Welberg L.,Heim C.,Wagner D.,Solomon L.,Papanicolaou D.A.,Craddock R.C.,Miller A.H.,Reeves W.C.,Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome,Neuropsychopharmacology,2006,31,8,1777-1784,DOI 10.1038/sj.npp.1301005, PII 1301005